Medtronic (NYSE:MDT) shares ticked up before hours today on second-quarter results that topped the consensus forecast. The Fridley, Minn.-based company posted profits of $494 million, or 36¢ per share, on sales of $7.6 billion for the three months ended Oct. 30, 2020, for a -64% bottom-line slide on a sales decline of 0.8%. Adjusted to exclude […]
MassDevice Earnings Roundup
SmileDirectClub beats The Street in Q3
SmileDirectClub (NSDQ:SDC) shares dipped before hours today on third-quarter results that beat the consensus forecast. The Nashville, Tenn.-based dental aligner maker posted losses of -$44.5 million, or -11¢ per share, on sales of $156.5 million for the three months ended Sept. 30, 2020, for an 88.8% bottom-line gain on a sales decline of -7.2%. Adjusted to […]
Titan Medical rises on Q3 results
Titan Medical (TSX:TMD;OTC:TITFX) shares ticked up today despite third-quarter results that include a massive decline in revenues. The Toronto-based robotic surgery company posted losses of -$1.6 million, or -2¢ per share, on sales of $4.5 million for the three months ended Sept. 30, 2020, for a -4.9% bottom-line slide on a sales decline of -75.5%. “Titan […]
MedTech 100 roundup: Stocks remain high after record-setting week
Medtech stocks have been on the rise since positive news regarding COVID-19 vaccines broke last week, breaking a record in the process. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 98.99 (Nov. 13), marking a 1.4% uptick from the 97.62 points registered at the […]
Electromed beats The Street’s EPS projections
Electromed (NSDQ:ELMD) shares dipped today despite first-quarter EPS results that topped the consensus forecast. The New Prague, Minn.-based airway clearance therapy technology developer posted profits of $535,262, or 6¢ per share, on sales of $8 million for the three months ended Sept. 30, 2020, for a -47.2% bottom-line slide on a sales decline of -3.6%. Adjusted […]
Myomo rises after hours on more than 200% revenue increase
Myomo (NYSE:MYO) shares ticked up after hours today on third-quarter results that topped the consensus forecast. MYO shares were up 15.9% at $5.60 per share after hours. The Cambridge, Mass.-based company posted losses of -$2.8 million, or -70¢ per share, on sales of $1.9 million for the three months ended Sept. 30, 2020, for a slight […]
CHF Solutions’ Q3 sales soar, shares still dip
CHF Solutions (NSDQ:CHFS) shares ticked down today despite third-quarter results that topped the consensus revenue forecast. The Eden Prairie, Minn.-based blood management technology developer posted losses of -$4.3 million, or -$2.08 per share, on sales of $1.9 million for the three months ended Sept. 30, 2020, for a minor bottom-line slide on sales growth of 52.1%. […]
TransEnterix beats The Street in Q3
TransEnterix (NYSE:TRXC) shares ticked up slightly on third-quarter results that came in ahead of the consensus forecast. The Research Triangle Park, N.C.-based surgical robotics company posted losses of -$15.1 million, or -15¢ per share, on sales of $814,000 for the three months ended Sept. 30, 2020, for an 84.6% bottom-line gain despite a sales decline of […]
MedTech 100 roundup: Stocks show no signs of slowing down
The medtech industry hit further highs in the market last week and the stocks show no sign of stopping their ascent now. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week at 97.62 (Nov. 6), marking a 7.3% leap from the 91.01 points registered at the […]
ICU Medical ticks up on Street-beating Q3, raised guidance
ICU Medical (NSDQ:ICUI) shares rose today on third-quarter results that came in ahead of the consensus forecast. The San Clemente, Calif.-based infusion therapy and critical care technology developer posted profits of $25 million, or $1.16 per share, on sales of $318.6 million for the three months ended Sept. 30, 2020, for a -5.9% bottom-line slide on […]
Nevro rises on Street-beating Q3
Nevro (NYSE:NVRO) shares ticked up today on third-quarter results that came in ahead of the consensus forecast. The Redwood City, Calif.-based chronic pain treatment developer posted losses of -$10 million, or -29¢ per share, on sales of $108.5 million for the three months ended Sept. 30, 2020, for a 44.1% bottom-line gain on sales growth of […]
